Patent directory · USPTO A61K / A61P
Patents matching “ras”
843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2025058008
CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE AYANT POUR ACTIVITÉ L'INDUCTION DE LA DÉCOMPOSITION DE LA PROTÉINE KRAS MUTANTE G12D
granted -
US 12251417
Antimicrobial compounds from the genus Delftia
granted -
US 12252497
Ras inhibitors
granted -
US 12251432
Biomarkers and immunogenic compositions for filarial parasites
granted -
US 12215321
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted -
US 12215322
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors
granted -
US 12213964
Isoxazoline parasiticide formulations
granted -
US 12209116
Recombinant human C1 esterase inhibitor and uses thereof
granted -
US 12202845
Ras inhibitors
granted -
CN 119343336
1, 4-bis-(2-hydroxy-benzyl)-1, 4, 7-triazacyclononane derivatives and similar compounds as ligands in iron (iii) complexes for use as MRI contrast agents
granted -
US 12201701
Vegetable oil-derived contrast agent with high stability and preparation method thereof
granted -
US 12187780
Car t-cells comprising inactivated CBL and CBL-B genes
granted -
US 12178626
Encapsulated gas or partial vacuum CT contrast material
granted -
US 12181555
3-dimensional representations of post-contrast enhanced brain lesions
granted -
WO 2024261256
COMPOSITION PHARMACEUTIQUE COMPRENANT UN AGENT DE DÉGRADATION PAN-KRAS
granted -
US 12171750
Isoxazoline parasiticide formulations and methods for treating blepharitis
granted -
US 12173088
Anti-microbial peptides
granted -
US 12168013
Antiviral prodrugs and nanoformulations thereof
granted -
US 12156912
Methods and compositions for inhibiting diseases of the central nervous system
granted -
US 12138274
Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases
granted -
US 12139522
T-cells comprising two different chimeric antigen receptors and uses thereof
granted -
US 12138301
Compounds including a mutant KRAS sequence and a lipid and uses thereof
granted -
US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted -
US 12123001
Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors
granted